Groningen

• A Mass Balance Study of [14C]-IPN60250 in Healthy Adult Participants Ended
  2024-515195-12-00 3 2025-02-18 Primary sclerosing cholangitis (PSC)
• Ceftobiprole OATP1B interaction study Ended
  2024-518592-60-00 3 2025-01-17 Community-acquired bacterial pneumonia
• A PHASE-1, FIRST-IN-HUMAN, RANDOMIZED, DOUBLE-BLIND, PLACEBO­-CONTROLLED, SINGLE AND MULTIPLE ASCENDING DOSE STUDY TO ASSESS THE SAFETY, TOL … Ended
  2023-507504-31-00 1 2025-01-14 Lupus erythematosus
• A Study Evaluating the Pharmacokinetics of Three QRL-101 Formulations in Healthy Participants Ended
  2024-518833-27-00 3 2025-01-10 Amyotrophic Lateral Sclerosis (ALS)
• A Randomised Double-Blinded, Placebo-Controlled, Single and Multiple Ascending Dose, Phase 1 Study to Evaluate the Safety, Tolerability, and … Ended
  2023-504838-21-00 1 2025-01-08 Healthy
• Mass balance study of [14C]-VAD044 Ended
  2024-518843-39-00 3 2024-12-31 Vascular malformation
• GENPAD Ended
  2024-518122-33-00 6 2024-12-13 Peripheral Arterial Disease
• TURN-COVID Biobank: The Dutch cohort study for the evaluation of the use of neutralizing monoclonal antibodies and other antiviral agents ag … Ended
  2024-515263-60-00 6 2024-11-22 SARS-CoV-2 infection
• A study investigating the effect of different approved medications on how the body processes the study compound RO7795081. RO7795081 is a ne … Ended
  2024-517360-37-00 3 2024-11-22 Type 2 Diabetes and obesity
• Optical PD-L1 imaging using Quantitative Fluorescence Endoscopy in locally advanced esophageal cancer using durvalumab-680LT: a phase I mult … Ended
  2024-517258-85-00 1 2024-11-21 Esophageal cancer
• Investigating the safety, feasibility, and optimal dose of risankizumab-800CW in IBD - NAVIGATE study Ended
  2024-515358-25-00 7 2024-11-08 Inflammatory Bowel Disease (IBD)
• A Study to Assess the Effectiveness of Different Doses of GEH200486 Injection for Contrast-enhanced Head and Neck MRI in Healthy Volunteers Ended
  2024-516751-41-00 2 2024-11-08 None - imaging technique
• Effects of DLX-001 on PD, Safety, Tolerability, and PK in Participants with MDD Ended
  2024-517139-29-00 3 2024-11-06 Major Depressive Disorder (MDD)
• DECISION; Digoxin Evaluation in Chronic heart failure: Investigational Study In Outpatients in the Netherlands Ended
  2023-509898-23-00 6 2024-11-01 heart failure
• A study to learn more about how BAY3283142 moves into, through, and out of the body of healthy participants when taken together with atazana … Ended
  2024-510856-11-00 3 2024-10-31 Chronic kidney disease
• A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, SINGLE AND MULTIPLE ASCENDING DOSE PHASE 1 STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, PH … Ended
  2024-514871-17-00 1 2024-10-29 Obesity
• A study investigating the safety, absorption, and elimination of radioactively labeled RO7269162, a new compound that may potentially be use … Ended
  2024-513234-37-00 3 2024-10-16 Healthy males volunteers
• A TWO-PART ABSOLUTE BIOAVAILABILITY STUDY DESIGNED TO EVALUATE THE PHARMACOKINETIC PROFILE OF VELUSETRAG FOLLOWING SINGLE-DOSE ADMINISTRATIO … Ended
  2024-513988-70-00 3 2024-10-07 chronic intestinal pseudo-obstruction (CIPO)
• A Phase 1 Open-Label Mass Balance clinical trial to Investigate the Absorption, Metabolism, and Excretion of Single Oral Administration of [ … Ended
  2024-515556-20-00 3 2024-10-07 Healthy participant
• A study in healthy men to learn about how the body absorbs, processes, and removes radioactively labeled BAY 3283142 Ended
  2024-510765-42-00 3 2024-10-01 Chronic kidney disease
• A research study on the effects of NNC0537-1482 in healthy individuals when injected under the skin. Ended
  2024-514431-18-00 1 2024-10-01 Heart Failure
• Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients with Moderate-to-Severe Asthma Uncontrolled on Medium-High Dos … Ended
  2023-506000-50-00 4 2024-09-26 Adult Patients with Moderate-to-Severe Asthma Uncontrolled on Medium-H
• A study in healthy men to test how BI 1839100 is taken up and handled by the body Ended
  2024-510870-26-00 3 2024-09-24 Healthy volunteer trial
• An open label, phase 1 study to evaluate the safety, feasibility and immunogenicity of an allogeneic, cell-based vaccine (VIDIDENCEL) in hig … Ended
  2024-516781-10-00 1 2024-09-16 High grade serous ovarian cancer

Showing 505–528 of 679 trials